Eneura Therapeutics
Country not established
- Devices
- 2
What Eneura Therapeutics makes
Eneura Therapeutics manufactures the Neuralieve Cerena, a transcranial magnetic stimulator designed for non-invasive brain stimulation therapy.
The company’s portfolio is regulated under FDA Class II devices, with the Neuralieve Cerena listed via the 510(k) pathway. The manufacturer is based in the United States.
Catalogue
Springtms Total Migraine System Ref K140094
Regimes: 510(k) Registry: 510(k)Neuralieve Cerena Transcranial Magnetic Stimulator Ref DEN130022
Regimes: De Novo Registry: De Novo
Frequently asked questions
How many devices does Eneura Therapeutics have in the registry?
The registry currently lists 2 devices for Eneura Therapeutics. Devices recorded under merged duplicate company entries are counted once.
Which registries list Eneura Therapeutics's devices?
Among its 2 most recently registered devices, Eneura Therapeutics has devices listed in FDA 510(k) (2 devices).
What risk classes do Eneura Therapeutics's devices fall under?
Among its 2 most recently registered devices, the classes recorded for Eneura Therapeutics's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Eneura Therapeutics in the registry?
The most recently registered devices listed for Eneura Therapeutics include SPRINGTMS TOTAL MIGRAINE SYSTEM and NEURALIEVE CERENA TRANSCRANIAL MAGNETIC STIMULATOR.